Regulatory news – prior January 2019

To view our latest Regulatory news please click here

Disclosure of Home Member State

Amsterdam, The Netherlands, February 19, 2016, – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing innovative T-cell immunotherapy treatments […]

19 February 2016

Read more

Kiadis Pharma notice of meeting of shareholders

Amsterdam, The Netherlands, October 28, 2015 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing innovative T-cell immunotherapy treatments […]

28 October 2015

Read more